MAXICORP INVESTIMENTOS E PARTICIPAÇÕES LTDA – Trademark Portfolio

Entity Type: 99

MAXICORP INVESTIMENTOS E PARTICIPAÇÕES LTDA holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 45 (Legal & Security Services) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include FINDMYANGEL. The owner is based in São Paulo SP.

Av. Angélica 819 – Suite 61 – Santa Cecília

São Paulo SP 01227-000 , BR

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

MAXICORP INVESTIMENTOS E PARTICIPAÇÕES LTDA's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

45
Legal & Security Services (1 filing)

Legal services; security services for the protection of property and individuals

Frequently Asked Questions

How many trademarks does MAXICORP INVESTIMENTOS E PARTICIPAÇÕES LTDA have?

MAXICORP INVESTIMENTOS E PARTICIPAÇÕES LTDA has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does MAXICORP INVESTIMENTOS E PARTICIPAÇÕES LTDA file in?

MAXICORP INVESTIMENTOS E PARTICIPAÇÕES LTDA files trademarks across 1 Nice Classification class. The most active classes are Class 45 (Legal & Security Services). Class 45 covers legal services; security services for the protection of property and individuals.

What are MAXICORP INVESTIMENTOS E PARTICIPAÇÕES LTDA's most well-known trademarks?

MAXICORP INVESTIMENTOS E PARTICIPAÇÕES LTDA's registered trademark portfolio includes well-known marks such as FINDMYANGEL. These are among 1 currently registered trademark in the portfolio.

What is MAXICORP INVESTIMENTOS E PARTICIPAÇÕES LTDA's trademark registration success rate?

MAXICORP INVESTIMENTOS E PARTICIPAÇÕES LTDA has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.